Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactamica 2: Neisseria lactamica to inhibit N. meningitidis carriage
NCT02249598Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jul 2013
- Primary completion
- Nov 2013
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial in meningococcal disease comparing Neisseria lactamica with Placebo (2 arms). Primary endpoint: Number of participants with Neisseria meningitidis carriage at 28 weeks. Started Jul 2013; status: completed.
02
Drugs
Neisseria lactamica
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT02249598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02249598.